E-LIB Suche - Ergebnisse für: Mutavhatsindi, Hygon

1

Baseline and end-of-treatment host serum biomarkers predict..:

Mutavhatsindi, Hygon ; Manyelo, Charles M. ; Snyders, Candice I....
Journal of Infection. 89 (2024) 1 - p. 106173 , 2024

Link: https://doi.org/10.1016/..

2

Blood and Site of Disease Inflammatory Profiles Differ in P..:

Mutavhatsindi, Hygon ; Du Bruyn, Elsa ; Ruzive, Sheena...
Open Forum Infectious Diseases. 10 (2023) 3 - p. , 2023

Link: https://doi.org/10.1093/..

3

Protocol to quantify and phenotype SARS-CoV-2-specific T ce..:

Mutavhatsindi, Hygon ; Riou, Catherine
STAR Protocols. 3 (2022) 4 - p. 101771 , 2022

Link: https://doi.org/10.1016/..

4

Serum and cerebrospinal fluid host proteins indicate stroke..:

Manyelo, Charles M. ; Chegou, Novel N. ; Seddon, James A....
PLOS ONE. 16 (2021) 4 - p. e0250944 , 2021

Link: https://doi.org/10.1371/..

5

Validation and Optimization of Host Immunological Bio-Signa..:

Mutavhatsindi, Hygon ; van der Spuy, Gian D. ; Malherbe, Stephanus T....
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

6

Identification of novel salivary candidate protein biomarke..:

Mutavhatsindi, Hygon ; Calder, Bridget ; McAnda, Shirley...
Tuberculosis. 130 (2021) - p. 102118 , 2021

Link: https://doi.org/10.1016/..

7

Prospective evaluation of host biomarkers other than interf..:

Manngo, Portia M. ; Gutschmidt, Andrea ; Snyders, Candice I....
Journal of Infection. 79 (2019) 3 - p. 228-235 , 2019

Link: https://doi.org/10.1016/..

8

Application of Cerebrospinal Fluid Host Protein Biosignatur..:

Manyelo, Charles M. ; Solomons, Regan S. ; Snyders, Candice I....
Mediators of Inflammation. 2019 (2019) - p. 1-11 , 2019

Link: https://doi.org/10.1155/..

9

OC 8435 MULTI-BIOMARKER TEST STRIP FOR POINT-OF-CARE SCREEN..:

Corstjens, Paul ; Hooij, Anouk Van ; Tjon Kon Fat, Elisa...
BMJ Global Health. 4 (2019) Suppl 3 - p. A6.2-A6 , 2019

Link: https://doi.org/10.1136/..

10

Potential of Host Serum Protein Biomarkers in the Diagnosis..:

Manyelo, Charles M. ; Solomons, Regan S. ; Snyders, Candice I....
Frontiers in Pediatrics. 7 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

11

Validation and Optimization of Host Immunological Bio-Signa..:

Mutavhatsindi, Hygon ; van der Spuy, Gian D ; Malherbe, Stephanus T...
https://boris.unibe.ch/154645/. , 2021

Link: https://boris.unibe.ch/1..

12

Validation and Optimization of Host Immunological Bio-Signa..:

Mutavhatsindi, Hygon ; van der Spuy, Gian D ; Malherbe, Stephanus T...
https://researchonline.lshtm.ac.uk/id/eprint/4661081/1/Mutavhatsindi_etal_2021_Validation-and-optimization-of-host.pdf. , 2021

Link: https://researchonline.l..

13

Protocol to quantify and phenotype SARS-CoV-2-specific T ce..:

Hygon Mutavhatsindi ; Catherine Riou
http://www.sciencedirect.com/science/article/pii/S2666166722006517. , 2022

Link: https://doi.org/10.1016/..

14

DataSheet_1_Validation and Optimization of Host Immunologic..:

figshare admin frontiersin ; Hygon Mutavhatsindi ; Gian D. van der Spuy...
doi:10.3389/fimmu.2021.607827.s001. , 2021

Link: https://doi.org/10.3389/..

15

Validation and Optimization of Host Immunological Bio-Signa..:

Hygon Mutavhatsindi ; Gian D. van der Spuy ; Stephanus T. Malherbe...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.607827/full. , 2021

Link: https://doi.org/10.3389/..